Michael Scharl
Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients.
Yoganathan P, Rossel J, Jordi S, Franc Y, Biedermann L, Misselwitz B, Hausmann M, Rogler G, Scharl M, Frey-Wagner I, Swiss IBD Cohort Study Group. Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients. BMC Gastroenterol 2021; 21:310.
Aug 3, 2021Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients.
Aug 3, 2021BMC Gastroenterol 2021; 21:310
Yoganathan Priyatharsan, Rossel Jean-Benoit, Jordi Sebastian Bruno Ulrich, Franc Yannick, Biedermann Luc, Misselwitz Benjamin, Hausmann Martin, Rogler Gerhard, Scharl Michael, Frey-Wagner Isabelle, Swiss IBD Cohort Study Group
Fatigue in inflammatory bowel disease and its impact on daily activities
Schreiner P, Misselwitz B, von Känel R, Rogler G, Juillerat P, Pittet V, Vavricka S, Scharl M, Greuter T, Baumann C, Valko P, Biedermann L, Rossel J, Swiss IBD Cohort Study Group. Fatigue in inflammatory bowel disease and its impact on daily activities. Aliment Pharmacol Ther 2020; 53:138-149.
Nov 7, 2020Fatigue in inflammatory bowel disease and its impact on daily activities
Nov 7, 2020Aliment Pharmacol Ther 2020; 53:138-149
Schreiner Philipp, Misselwitz Benjamin, von Känel Roland, Rogler Gerhard, Juillerat Pascal, Pittet Valérie, Vavricka Stephan R, Scharl Michael, Greuter Thomas, Baumann Christian R, Valko Philipp O, Biedermann Luc, Rossel Jean-Benoit, Swiss IBD Cohort Study Group
The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation
Tcymbarevich I, Misselwitz B, de Vallière C, Rogler G, Ruiz P, Seuwen K, Scharl M, Wagner C, Kullak-Ublick G, Lang S, Cosin-Roger J, Spalinger M, Obialo N, Rossel J, Eloranta J, Swiss IBD Cohort Study Group. The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation. BMC Gastroenterol 2019; 19:2.
Jan 7, 2019The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation
Jan 7, 2019BMC Gastroenterol 2019; 19:2
Tcymbarevich Irina V, Misselwitz Benjamin, de Vallière Cheryl, Rogler Gerhard, Ruiz Pedro A, Seuwen Klaus, Scharl Michael, Wagner Carsten A, Kullak-Ublick Gerd A, Lang Silvia, Cosin-Roger Jesus, Spalinger Marianne, Obialo Nicole, Rossel Jean-Benoit, Eloranta Jyrki J, Swiss IBD Cohort Study Group
Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey
Vavricka S, Biedermann L, Michetti P, Straumann A, Misselwitz B, Scharl M, Manser C, Greuter T, Zeitz J, Frei P, Borovicka J, Seibold F, Schoepfer A, Rogler G, Spasojevic M. Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey. Dig Dis 2017; 35:423-432.
Jun 9, 2017Long-Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey
Jun 9, 2017Dig Dis 2017; 35:423-432
Vavricka Stephan R, Biedermann Luc, Michetti Pierre, Straumann Alex, Misselwitz Benjamin, Scharl Michael, Manser Christine, Greuter Thomas, Zeitz Jonas, Frei Pascal, Borovicka Jan, Seibold Frank, Schoepfer Alain M, Rogler Gerhard, Spasojevic Milos
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Vavricka S, Misselwitz B, Scharl M, Heinrich H, Manser C, Safroneeva E, Raja Ali R, Rogler G, Schoepfer A, Greuter T, Zeitz J, Biedermann L, Juillerat P, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, Michetti P, Straumann A, Fournier N. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Inflamm Bowel Dis 2017
Apr 27, 2017Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Apr 27, 2017Inflamm Bowel Dis 2017
Vavricka Stephan R, Misselwitz Benjamin, Scharl Michael, Heinrich Henriette, Manser Christine N, Safroneeva Ekaterina, Raja Ali Raja Affendi, Rogler Gerhard, Schoepfer Alain M, Greuter Thomas, Zeitz Jonas, Biedermann Luc, Juillerat Pascal, Gubler Martin, Gantenbein Claudine, Spoerri Muriel, Froehlich Florian, Seibold Frank, Protic Marijana, Michetti Pierre, Straumann Alex, Fournier Nicolas
Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort
Zeitz J, Rogler G, Fried M, Sulz M, Vavricka S, Scharl S, Misselwitz B, Frei P, Biedermann L, Labenz C, Fournier N, Scharl M. Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort. Inflamm Intest Dis 2017; 1:172-181.
Feb 25, 2017Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort
Feb 25, 2017Inflamm Intest Dis 2017; 1:172-181
Zeitz Jonas, Rogler Gerhard, Fried Michael, Sulz Michael, Vavricka Stephan R, Scharl Sylvie, Misselwitz Benjamin, Frei Pascal, Biedermann Luc, Labenz Christian, Fournier Nicolas, Scharl Michael
Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience
Bontà J, Rogler G, Fried M, Scharl S, Vavricka S, Sulz M, Biedermann L, Frei P, Zeitz J, Scharl M. Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience. Eur J Gastroenterol Hepatol 2016; 28:1329-34.
Nov 1, 2016Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience
Nov 1, 2016Eur J Gastroenterol Hepatol 2016; 28:1329-34
Bontà Jonas, Rogler Gerhard, Fried Michael, Scharl Sylvie, Vavricka Stephan R, Sulz Michael, Biedermann Luc, Frei Pascal, Zeitz Jonas, Scharl Michael
Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort
Spalinger M, Scharl M, Rogler G, Fried M, Vavricka S, Scharl S, Frei P, Sulz M, Rossel J, Biedermann L, Zeitz J. Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort. PloS one 2016; 11:e0160215.
Jul 28, 2016Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort
Jul 28, 2016PloS one 2016; 11:e0160215
Spalinger Marianne R, Scharl Michael, Rogler Gerhard, Fried Michael, Vavricka Stephan R, Scharl Sylvie, Frei Pascal, Sulz Michael, Rossel Jean-Benoit, Biedermann Luc, Zeitz Jonas
Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience
Madanchi M, Rogler G, Vavricka S, Frei P, Biedermann L, Sulz M, Scharl S, Samaras P, Barthel C, Zeitz J, Scharl M. Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience. Digestion 2016; 94:1-8.
Jun 18, 2016Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience
Jun 18, 2016Digestion 2016; 94:1-8
Madanchi Mehdi, Rogler Gerhard, Vavricka Stephan R, Frei Pascal, Biedermann Luc, Sulz Michael, Scharl Sylvie, Samaras Panagiotis, Barthel Christiane, Zeitz Jonas, Scharl Michael
The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease
Vögelin M, Rogler G, Fried M, Sulz M, Zeitz J, Scharl S, Vavricka S, Frei P, Biedermann L, Scharl M. The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease. PloS one 2016; 11:e0155218.
May 23, 2016The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease
May 23, 2016PloS one 2016; 11:e0155218
Vögelin Marius, Rogler Gerhard, Fried Michael, Sulz Michael, Zeitz Jonas, Scharl Sylvie, Vavricka Stephan R, Frei Pascal, Biedermann Luc, Scharl Michael
The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort
Spalinger M, Scharl M, Rogler G, Fried M, Vavricka S, Scharl S, Frei P, Sulz M, Rossel J, Zeitz J, Biedermann L, Voegelin M. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort. Digestion 2016; 93:182-92.
Feb 27, 2016The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort
Feb 27, 2016Digestion 2016; 93:182-92
Spalinger Marianne R, Scharl Michael, Rogler Gerhard, Fried Michael, Vavricka Stephan R, Scharl Sylvie, Frei Pascal, Sulz Michael, Rossel Jean-Benoit, Zeitz Jonas, Biedermann Luc, Voegelin Marius
Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient survey
Barthel C, Rogler G, Wiegand N, Sulz M, Fried M, Vavricka S, Frei P, Scharl M, Scharl S, Wiegand S, Biedermann L. Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient survey. Nutr J 2015; 14:78.
Aug 12, 2015Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient survey
Aug 12, 2015Nutr J 2015; 14:78
Barthel Christiane, Rogler Gerhard, Wiegand Nico, Sulz Michael, Fried Michael, Vavricka Stephan R, Frei Pascal, Scharl Michael, Scharl Sylvie, Wiegand Sandra, Biedermann Luc
Uncommon case of brain metastasis in a patient with a history of heavy smoking.
Scharl M, Bode B, Rushing E, Knuth A, Rordorf T. Uncommon case of brain metastasis in a patient with a history of heavy smoking. Curr Oncol 2014; 21:e728-31.
Oct 1, 2014Uncommon case of brain metastasis in a patient with a history of heavy smoking.
Oct 1, 2014Curr Oncol 2014; 21:e728-31
Scharl Michael, Bode B, Rushing Elisabeth Jane, Knuth A, Rordorf Tamara
Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Vavricka S, Michetti P, Straumann A, Seibold F, Scharl M, Sauter B, de Saussure P, Rogler G, Manz M, Geyer M, Felley C, Binek J, Bansky G, Schoepfer A, for the Swiss IBDnet. Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflamm Bowel Dis 2010
Dec 22, 2010Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey
Dec 22, 2010Inflamm Bowel Dis 2010
Vavricka Stephan R, Michetti Pierre, Straumann Alex, Seibold Frank, Scharl Michael, Sauter Bernhard, de Saussure Philippe, Rogler Gerhard, Manz Michael, Geyer Martin, Felley Christian, Binek Janek, Bansky Georg, Schoepfer Alain M, for the Swiss IBDnet